|
Market Closed -
Nasdaq
00:00:00 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.580 USD | -1.08% |
|
-3.98% | -5.18% |
| 08-07 | Relmada Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-07 | Relmada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.08% | -3.98% | -11.58% | -34.94% | -5.18% | +630.46% | +43.57% | -81.36% | -26.13% | 489M | |
| -4.31% | -6.62% | +24.67% | +49.87% | +71.93% | +65.79% | +98.02% | +19.08% | - | 69.06B | |
| -4.19% | +1.05% | +7.43% | +23.28% | +20.56% | +52.79% | +85.53% | +200.07% | +6,296.74% | 63.06B | |
| -3.22% | +23.17% | +26.30% | +22.44% | +18.51% | +1.75% | -5.23% | -69.36% | - | 28.34B | |
| -1.42% | -3.38% | +15.96% | +16.70% | -28.76% | -5.99% | +465.34% | +386.39% | +877.76% | 27.07B | |
| +5.25% | +4.78% | +31.66% | +48.05% | +61.90% | +52.94% | +14.77% | -57.97% | - | 25.45B | |
| -1.81% | +0.38% | +12.43% | +22.54% | +4.19% | +34.52% | -18.33% | -29.48% | +87.57% | 19.69B | |
| +5.36% | +4.61% | +29.96% | +102.00% | +248.12% | +270.18% | +415.10% | +1,940.14% | +961.83% | 19.19B | |
| -0.96% | -4.42% | +0.97% | +12.04% | +32.20% | +10.37% | +513.25% | - | - | 15.95B | |
| +0.87% | +4.26% | -1.48% | +8.77% | +24.46% | +41.21% | +150.80% | +188.17% | +401.84% | 13.52B | |
| -0.44% | -2.22% | +1.32% | +15.72% | +30.64% | +306.61% | +209.31% | +37.80% | +1,158.78% | 12.25B | |
| -0.92% | -2.46% | -5.98% | -1.02% | -12.08% | +23.46% | +188.81% | +522.46% | +5,387.35% | 11.83B | |
| +0.33% | +1.61% | -4.52% | +0.19% | +21.33% | +101.07% | +128.89% | +144.42% | +547.82% | 10.72B | |
| +0.74% | -1.81% | -9.38% | -20.37% | -20.93% | -47.29% | +170.35% | +123.93% | - | 10.39B | |
| -3.27% | -0.39% | -6.81% | -23.41% | -27.22% | -51.41% | +615.17% | +57.16% | +88.44% | 10.16B | |
| +0.15% | +1.96% | +4.43% | +44.02% | +225.55% | +513.64% | +681.32% | -40.42% | -26.32% | 9.4B | |
| -1.20% | +2.74% | +13.19% | +30.80% | +34.09% | +91.61% | +25.32% | +158.65% | - | 9.21B | |
| +0.11% | +0.04% | +1.25% | +130.38% | +82.13% | +174.19% | +393.19% | +274.80% | - | 8.99B | |
| +8.15% | +1.14% | -6.54% | -4.47% | +11.18% | -9.75% | +117.82% | -23.98% | - | 8.09B | |
| -2.70% | -4.29% | +6.76% | +4.99% | +282.83% | +228.14% | +373.75% | -32.74% | - | 8.03B | |
| Average | -0.24% | +0.59% | +6.50% | +22.38% | +53.77% | +124.21% | +233.34% | +195.67% | +1,432.33% | 19.04B | |
| Weighted average by Cap. | -1.33% | +0.89% | +12.79% | +30.26% | +49.29% | +76.40% | +186.85% | +200.76% | +2,689.79% |
- Stock Market
- Stocks
- RLMD Stock
- Sector Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
